Awards Unsolicited Proposal for the Health Communication Initiative Program, 49386-49387 [2020-17516]

Download as PDF 49386 Federal Register / Vol. 85, No. 157 / Thursday, August 13, 2020 / Notices TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS Number of responses per respondent Number of respondents Form name Total responses Average burden per response (in hours) Total burden hours Teaching Health Center Costing Instrument ....................... 56 1 56 10 560 Total .............................................................................. 56 ........................ 56 ........................ 560 Maria G. Button, Director, Executive Secretariat. Authority: 42 U.S.C. 1395. [FR Doc. 2020–17729 Filed 8–12–20; 8:45 am] Alex M. Azar II, Secretary. BILLING CODE 4165–15–P [FR Doc. 2020–17748 Filed 8–12–20; 8:45 am] BILLING CODE 4150–03–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Indian Health Service Delegation of Authority [Assistance Listing Number 93.933] Notice is hereby given that I have delegated jointly to the Administrator, Centers for Medicare & Medicaid Services (CMS), and to the Director, National Institutes of Health (NIH), the authorities vested in the Secretary under Section 1881(c)(7)(B)–(E) [42 U.S.C. 1395rr(c)(7)(B)–(E)] of the Social Security Act (the Act), as amended, to assemble and analyze data reported by network organizations, transplant centers, and other sources on all endstage renal disease (ESRD) patients. Limitations This delegation of authorities under Section 1881(c)(7)(B)–(E) [42 U.S.C. 1395rr(c)(7)(B)–(E)] of the Act shall be shared between CMS and NIH as these authorities relate to their respective programs. CMS and NIH will implement proactive collaborative measures such as ongoing status checks to discuss progress and resolve any potential disputes. This delegation supersedes any prior delegations under this section, including the delegation dated September 6, 1984 (49 FR 35247). This delegation of authority may be re-delegated. This delegation of authority is effective immediately. I hereby affirm and ratify any actions taken by the Administrator, CMS, and the Director, NIH, or their subordinates, which involved the exercise of authority under Section 1881(c)(7)(B)–(E) [42 U.S.C. 1395rr(c)(7)(B)–(E)] of the Act, as amended, delegated herein prior to the effective date of this delegation of authority. VerDate Sep<11>2014 17:16 Aug 12, 2020 Jkt 250001 Awards Unsolicited Proposal for the Health Communication Initiative Program Office of Clinical and Preventive Services, Indian Health Service, Department of Health and Human Services. ACTION: Notice of award of a singlesource unsolicited grant to Johns Hopkins University in Baltimore, Maryland. AGENCY: Recipient: Johns Hopkins University, Baltimore, Maryland. Purpose of the Award: Cooperative agreement to collect, develop, package and distribute information to American Indian and Alaska Native (AI/AN) communities to address the coronavirus disease 2019 (COVID–19)-specific recommendations on healthcare, in a culturally sensitive way. Amount of Award: $127,644 in Fiscal Year (FY) 2020. Period of Performance: April 24, 2020–August 24, 2020. SUMMARY: The Office of Clinical and Preventive Services (OCPS) announces the award of a single-source cooperative agreement in response to an unsolicited proposal from Johns Hopkins University, Baltimore, Maryland. The proposal submitted was not solicited either formally or informally by any federal government official. OCPS performed an objective review of the unsolicited proposal from Johns Hopkins University (JHU) to develop information on proper actions to mitigate the spread of COVID–19, in a culturally sensitive way. The Johns Hopkins Bloomberg School of Public Health (JHSPH) Center for American PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 Indian Health (CAIH) mission is to work in partnerships with AI/AN communities to raise their health status, self-sufficiency, and health leadership to the highest possible level. This mission is accomplished through research, training and education, and service. The CAIH has more than nine facilities and approximately 100 staff in the Southwestern tribal communities to assist the Indian Health Service (IHS) in containing and mitigating COVID–19, while building a response model and set of communication materials for all IHS regions nationwide. The CAIH can draw on broad expertise from JHU for additional guidance and recommendations on best practices as the situation evolves. The materials will be developed from the Centers for Disease Control and Prevention (CDC) and the Substance Abuse and Mental Health Services Administration (SAMHSA) guidance. Based on an internal review of the proposal and the immediate response of the IHS to address the COVID–19 public health emergency, OCPS determined that the proposal has merit. The long history between the federal government and Native American Tribes and people has often been less than ideal. There are still barriers to the Native American community accepting instruction or direction from the federal government. There is great value in having a third party that has a good history with the community to gather, package and deliver recommendations, in a culturally sensitive way, on staying safe from this disease, when those recommendations may run contrary to cultural norms. This delivery avenue will be more acceptable to the community, and will be more readily recognized for implementation within AI/AN communities. This award is being made noncompetitively because there is no current, pending, or planned funding opportunity announcement under which this proposal could be competed. OCPS has identified two additional key reasons to support rationale for awarding this unsolicited proposal: 1. The JHU CAIH is well known in the AI/AN communities for robust E:\FR\FM\13AUN1.SGM 13AUN1 Federal Register / Vol. 85, No. 157 / Thursday, August 13, 2020 / Notices communication/messaging networks, research, training, and subject matter expertise. The dissemination of critical COVID–19 information for tribal communities builds trust, credibility, and integrity of promoting a culturally sensitive public health approach around the information. 2. The JHU CAIH is uniquely positioned to provide culturally specific subject matter expertise drawn from a direct care services or ‘‘boots on the ground’’ approach. The CAIH has nearly 40 years of collaboration with Native American tribes and supports public health interventions in more than 140 tribal communities in over 21 states. The breadth of knowledge and existing partnerships will enhance dissemination of information nationally. Legislative Authority: The Snyder Act, 25 U.S.C. Section 13; the Indian Health Care Improvement Act, 25 U.S.C. Section 1621b; and Coronavirus Aid, Relief, and Economic Security (CARES) Act, Public Law 116–136. FOR FURTHER INFORMATION CONTACT: Audrey Solimon at Audrey.Solimon@ ihs.gov or by telephone at 301–590– 5421. Michael D. Weahkee, RADM, Assistant Surgeon General, U.S. Public Health Service, Director, Indian Health Service. [FR Doc. 2020–17516 Filed 8–12–20; 8:45 am] BILLING CODE 4165–16–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Advisory Council for Biomedical Imaging and Bioengineering. The meeting will be open to the public by videocast as indicated below. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. VerDate Sep<11>2014 17:16 Aug 12, 2020 Jkt 250001 Name of Committee: National Advisory Council for Biomedical Imaging and Bioengineering. Date: September 15, 2020. Open: 12:00 p.m. to 3:00 p.m. Agenda: Report from the Institute Director and other Institute Staff. Place: National Institutes of Health, Democracy II, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Closed: 3:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Democracy II, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: David T. George, Ph.D., Associate Director, Office of Research Administration, National Institute of Biomedical Imaging and Bioengineering, 6707 Democracy Boulevard, Room 920, Bethesda, MD 20892, georged@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: http:// www.nibib1.nih.gov/about/NACBIB/ NACBIB.htm, where an agenda and any additional information for the meeting will be posted when available. 49387 listed in the Supplementary Information section of this notice. Upon expiration of the evaluation period the granted licenses may be converted into a fully exclusive patent commercialization license for the term of the last to expire of the patent estate upon the company providing NHLBI with a commercial development plan supporting such a conversion. This notice is intended to apprise the public of a aforementioned license and provide a fifteen (15) day notice period for the objection. DATES: Only written comments and/or applications for a license which are received by the National Heart, Lung, and Blood Institute on or before August 28, 2020 will be considered. ADDRESSES: Requests for copies of patent applications (electronic only), inquiries, and comments relating to the contemplated an exclusive patent license should be emailed to: Michael Shmilovich, Esq., Senior Licensing and Patent Manager, 31 Center Drive Room 4A29, MSC2479, Bethesda, MD 20892– 2479, phone number 301–435–5019 shmilovm@nih.gov. SUPPLEMENTARY INFORMATION: Intellectual Property (Patent Estate) HHS Ref. No. E–036–2015–0 and –1, U.S. Provisional Patent Application 62/ 079,975 filed November 14, 2014 Dated: August 7, 2020. (expired), International Patent Miguelina Perez, Application PCT/US2015/060646 filed Program Analyst, Office of Federal Advisory November 13, 2015 (nationalized), U.S. Committee Policy. Patent Application 15/525,921 having [FR Doc. 2020–17678 Filed 8–12–20; 8:45 am] an effective filing date of November 13, 2015, and U.S. Divisional Patent BILLING CODE 4140–01–P Application 16/985,797 filed August 5, 2020, any and all continuation or DEPARTMENT OF HEALTH AND divisional applications claiming priority HUMAN SERVICES to any of the above. The patent rights in these inventions National Institutes of Health have been assigned or exclusively licensed to the Government of the Prospective Grant of an Exclusive United States of America. Start-Up Patent License for Evaluation: The prospective exclusive license Immunotherapy for Relapsed/ territory may be worldwide and in field Refractory Diffuse Large B Cell of use that may be limited to Lymphoma Immunotherapy against relapsed or refractory diffuse large B cell AGENCY: National Institutes of Health, lymphoma, and where the ‘‘Licensed Health and Human Services (HHS). Products’’ may be defined to be limited ACTION: Notice. to transgenically modified allogeneic SUMMARY: The National Heart, Lung, and natural killer cells within the scope of Blood Institute, of the National the Licensed Patent Rights that Institutes of Health, Department of transiently express one or more of a (1) Health and Human Services, is CCR7 receptor, (2) CD16a (HA–CD16), contemplating the grant of an exclusive (3) a DR5 specific TRAIL, or (4) CD19 start-up patent license for evaluation to chimeric antigen receptor. The aforementioned patent estates ONK Therapeutics, a start-up company spun-off from the National University of cover methods of treating a subject with Ireland Galway, and incorporated under a tumor by administering transgenically modified adoptive NK (natural killer the laws of the Republic of Ireland, to cells), methods of generating transgenic practice, for a limited time, the NK cells, and transgenic NK cells per se. inventions covered by the patent estate PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 E:\FR\FM\13AUN1.SGM 13AUN1

Agencies

[Federal Register Volume 85, Number 157 (Thursday, August 13, 2020)]
[Notices]
[Pages 49386-49387]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-17516]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Indian Health Service

[Assistance Listing Number 93.933]


Awards Unsolicited Proposal for the Health Communication 
Initiative Program

AGENCY: Office of Clinical and Preventive Services, Indian Health 
Service, Department of Health and Human Services.

ACTION: Notice of award of a single-source unsolicited grant to Johns 
Hopkins University in Baltimore, Maryland.

-----------------------------------------------------------------------

    Recipient: Johns Hopkins University, Baltimore, Maryland.
    Purpose of the Award: Cooperative agreement to collect, develop, 
package and distribute information to American Indian and Alaska Native 
(AI/AN) communities to address the coronavirus disease 2019 (COVID-19)-
specific recommendations on healthcare, in a culturally sensitive way.
    Amount of Award: $127,644 in Fiscal Year (FY) 2020.
    Period of Performance: April 24, 2020-August 24, 2020.
SUMMARY: The Office of Clinical and Preventive Services (OCPS) 
announces the award of a single-source cooperative agreement in 
response to an unsolicited proposal from Johns Hopkins University, 
Baltimore, Maryland. The proposal submitted was not solicited either 
formally or informally by any federal government official.
    OCPS performed an objective review of the unsolicited proposal from 
Johns Hopkins University (JHU) to develop information on proper actions 
to mitigate the spread of COVID-19, in a culturally sensitive way. The 
Johns Hopkins Bloomberg School of Public Health (JHSPH) Center for 
American Indian Health (CAIH) mission is to work in partnerships with 
AI/AN communities to raise their health status, self-sufficiency, and 
health leadership to the highest possible level. This mission is 
accomplished through research, training and education, and service. The 
CAIH has more than nine facilities and approximately 100 staff in the 
Southwestern tribal communities to assist the Indian Health Service 
(IHS) in containing and mitigating COVID-19, while building a response 
model and set of communication materials for all IHS regions 
nationwide. The CAIH can draw on broad expertise from JHU for 
additional guidance and recommendations on best practices as the 
situation evolves.
    The materials will be developed from the Centers for Disease 
Control and Prevention (CDC) and the Substance Abuse and Mental Health 
Services Administration (SAMHSA) guidance. Based on an internal review 
of the proposal and the immediate response of the IHS to address the 
COVID-19 public health emergency, OCPS determined that the proposal has 
merit.
    The long history between the federal government and Native American 
Tribes and people has often been less than ideal. There are still 
barriers to the Native American community accepting instruction or 
direction from the federal government. There is great value in having a 
third party that has a good history with the community to gather, 
package and deliver recommendations, in a culturally sensitive way, on 
staying safe from this disease, when those recommendations may run 
contrary to cultural norms. This delivery avenue will be more 
acceptable to the community, and will be more readily recognized for 
implementation within AI/AN communities.
    This award is being made noncompetitively because there is no 
current, pending, or planned funding opportunity announcement under 
which this proposal could be competed. OCPS has identified two 
additional key reasons to support rationale for awarding this 
unsolicited proposal:
    1. The JHU CAIH is well known in the AI/AN communities for robust

[[Page 49387]]

communication/messaging networks, research, training, and subject 
matter expertise. The dissemination of critical COVID-19 information 
for tribal communities builds trust, credibility, and integrity of 
promoting a culturally sensitive public health approach around the 
information.
    2. The JHU CAIH is uniquely positioned to provide culturally 
specific subject matter expertise drawn from a direct care services or 
``boots on the ground'' approach. The CAIH has nearly 40 years of 
collaboration with Native American tribes and supports public health 
interventions in more than 140 tribal communities in over 21 states. 
The breadth of knowledge and existing partnerships will enhance 
dissemination of information nationally.
    Legislative Authority: The Snyder Act, 25 U.S.C. Section 13; the 
Indian Health Care Improvement Act, 25 U.S.C. Section 1621b; and 
Coronavirus Aid, Relief, and Economic Security (CARES) Act, Public Law 
116-136.

FOR FURTHER INFORMATION CONTACT: Audrey Solimon at 
[email protected] or by telephone at 301-590-5421.

Michael D. Weahkee,
RADM, Assistant Surgeon General, U.S. Public Health Service, Director, 
Indian Health Service.
[FR Doc. 2020-17516 Filed 8-12-20; 8:45 am]
BILLING CODE 4165-16-P